A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours

Clinical trial NCT06682780 · RECRUITING

Trial details

NCT number: NCT06682780
Sponsor: LaNova Medicines Limited
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2025-09-17
Primary completion: 2028-12-25
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.